Learn more

UNIV LEUVEN KATH

Overview
  • Total Patents
    1,870
  • GoodIP Patent Rank
    1,740
  • Filing trend
    ⇧ 30.0%
About

UNIV LEUVEN KATH has a total of 1,870 patent applications. It increased the IP activity by 30.0%. Its first patent ever was published in 1983. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM), ICHAN SCHOOL OF MEDICINE AT MOUNT SINAI and UNIV ESTADUAL PAULISTA JULIO DE MESQUITA FILHO UNESP.

Patent filings per year

Chart showing UNIV LEUVEN KATHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Marchand Arnaud 97
#2 Neyts Johan 81
#3 Dallmeier Kai 65
#4 Chaltin Patrick 62
#5 Christ Frauke 54
#6 Debyser Zeger 53
#7 Carlens Gunter 47
#8 Voet Arnout 46
#9 Marchand Damien 46
#10 Smets Wim 44

Latest patents

Publication Filing date Title
GB202103184D0 Prognosis of chronic inflammatory demyelinating polyneuropathy
GB202101074D0 Engineering neurovascular organoids with 3D printed microfluidic chips
GB202100654D0 Process for preparing a foodstuff
GB202100528D0 Hydrogen storage
GB202100381D0 Automatic vending apparatus
GB202020507D0 Oat-based biscuit with slowly available glucose
GB202017122D0 Lignocellulose refinery
GB202016774D0 Methods for NA detection
WO2021064193A1 Method and apparatus for determining a measure of speech intelligibility
WO2021058722A1 Large vectors and methods for high-yield production
GB202014687D0 Activation and pressure balancing mechanism
WO2021048402A1 Lassavirus vaccines
GB202013912D0 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2
WO2021048003A1 Chimeric filovirus vaccines
GB202013538D0 Coronavirus mutants
GB202014686D0 Volumetric sample inlet
GB202011741D0 Engineered composition of aromatic compounds
GB202010520D0 Phase-inversion based PVDF-filters for aerosol, air and liquid filtration
GB202010479D0 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2
GB202010158D0 Creatinine clearance prediction